Efficacy and safety of dulaglutide vs metformin in type 2 diabetes (AWARD-3)

被引：0
|
作者：
Tofe Povedano, S. [1 ]
Umpierrez, G. [2 ]
Perez Manghi, F. [3 ]
Shurzinske, L. [4 ]
Pechtner, V. [5 ]
机构：
[1] Clin Juaneda, Palma De Mallorca, Spain
[2] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA USA
[3] Ctr Invest Metab CINME, Buenos Aires, DF, Argentina
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Neuilly Sur Seine, France
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Once-Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and/or a Sulfonylurea in Predominantly Asian Patients with Type 2 Diabetes
    Wang, Weiqing
    Ruiz, Luis Nevarez
    Filippova, Ekaterina
    Song, Ki-Ho
    Gu, Liqun
    Li, Pengfei
    Yang, Jun
    DIABETES, 2015, 64 : A74 - A74
  • [22] Efficacy and safety of once weekly dulaglutide versus once daily liraglutide in type 2 diabetes (AWARD6)
    Tofe Povedano, S.
    Dungan, K. M.
    Forst, T.
    Gonzalez Gonzalez, J. G.
    Atisso, C.
    Sealls, W.
    Fahrbach, J. L.
    DIABETOLOGIA, 2014, 57 : S23 - S23
  • [23] 1.2 Efficacy and Safety of Dulaglutide versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1) (66-OR)
    Carol H. Wysham
    Thomas C. Blevins
    Richard Arakaki
    Gildred Colon
    Pedro Garcia
    Charles Atisso
    Debra Kuhstoss
    Jamie Scism-Bacon
    Mark Lakshmanan
    Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 75 - 76
  • [24] Type 2 diabetes and CKD: safety of metformin vs sulfonylureas
    Reactions Weekly, 2020, 1787 (1) : 12 - 12
  • [25] Efficacy and Safety by Duration of Diabetes with Once-Weekly Dulaglutide in the AWARD Program
    Gallwitz, Baptist
    Pavo, Imre
    Thieu, Vivian
    Jia, Nan
    Zhang, Nan
    Garcia-Perez, Luis-Emilio
    DIABETES, 2016, 65 : A269 - A269
  • [26] The acute efficacy and safety of dulaglutide in Japanese adults with type 2 Diabetes Mellitus
    Mizoguchi, Asako
    Imamine, Rui
    Kusama, Minoru
    Mase, Hajime
    Sato, Ai
    Minatoguchi, Makiko
    Watarai, Atsuko
    Kawamura, Takahiko
    Hotta, Nigishi
    Nakashima, Eitaro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S109 - S109
  • [27] Efficacy, Safety and Treatment Satisfaction of Glimepiride vs Sitagliptin in Combination with Metformin in Type 2 Diabetes Mellitus
    Kumar, Subodh
    Pathak, Anuj Kumar
    Saikia, Dibyajyoti
    Kumar, Amish
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (12) : FC07 - FC10
  • [28] Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin
    Frias, Juan P.
    Wynne, Alan G.
    Matyjaszek-Matuszek, Beata
    Bartaskova, Dagmar
    Cox, David A.
    Woodward, Brad
    Li, Ying G.
    Tham, Lai S.
    Milicevic, Zvonko
    DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2048 - 2057
  • [29] Efficacy and safety of once-weekly dulaglutide versus insulin glargine in combination with metformin and/or sulfonylurea in Chinese patients with type 2 diabetes
    Wang, Weiqing
    Li, Pengfei
    Gu, Liqun
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [30] Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1) (vol 37, pg 2159, 2014)
    Wysham, Carol
    Blevins, Thomas
    Arakaki, Richard
    Colon, Gildred
    Garcia, Pedro
    Atisso, Charles
    Kuhstoss, Debra
    Lakshmanan, Mark
    DIABETES CARE, 2014, 37 (10) : 2895 - 2895
12345